CELLINK launches new tissue model kits

The new tissue model kits were developed to provide customers with tissue-specific bioinks and antibodies. The kits include antibodies from Atlas Antibodies, a collaborator with extensive experience in antibody development and production.

CELLINK, the world’s first bioink company and a global leader in bioprinter systems and bioinks, continues innovating new ways to strengthen its position in the field.  

Today, CELLINK is announcing the launch of two new tissue model kits — CELLINK SKIN Kit and CELLINK LIVER Kit. These kits give users valuable information about the phenotype of their tissue models. This insight enables better understanding of tissue health and helps researchers develop reliable tissue models for drug screening and cosmetic testing. With this launch, we continue to grow our product portfolio and offer an increasingly extensive range of tools to enhance research worldwide.

These kits are commercially available now through CELLINK and partners. This launch is the first of a multiphase initiative to better serve the needs of our collaborators.

For more information, please contact:

Erik Gatenholm, CEO                                                                                  Gusten Danielsson, CFO

Phone: EU +46 73 267 00 00                                                                      Phone: +46 70 991 86 04
US +1 (650) 515 5566                                                                                 US +1 (857) 332 2138 

Email: eg@cellink.com                                                                              Email: gd@cellink.com

About CELLINK

CELLINK is the leading 3D bioprinter provider and the first bioink company in the world. We focus on developing and commercializing bioprinting technologies to allow researchers to print human organs and tissues for pharmaceutical and cosmetic applications. Founded in 2016 and active in more than 50 countries, CELLINK is changing the future of medicine as we know it. Visit www.cellink.com to learn more. CELLINK is listed on Nasdaq First North under CLNK. Erik Penser Bank AB is the company’s certified adviser, available by phone at +46 846 383 00 and by email at: certifiedadviser@penser.se.

About Us

CELLINK has created one of the world's first universal Bioinks currently used by many of the world's most renowned research institutions. A Bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in 3D-Bioprinters. CELLINKs universal Bioink show excellent results and can be used in both CELLINKs proprietary 3D Bioprinters and its’ competitors.

Subscribe

Documents & Links